DE602005024161D1 - Peptid mit antitumoraler wirkung - Google Patents
Peptid mit antitumoraler wirkungInfo
- Publication number
- DE602005024161D1 DE602005024161D1 DE602005024161T DE602005024161T DE602005024161D1 DE 602005024161 D1 DE602005024161 D1 DE 602005024161D1 DE 602005024161 T DE602005024161 T DE 602005024161T DE 602005024161 T DE602005024161 T DE 602005024161T DE 602005024161 D1 DE602005024161 D1 DE 602005024161D1
- Authority
- DE
- Germany
- Prior art keywords
- peptide
- peptides
- antitumoral effect
- analogs
- fragments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62622004P | 2004-11-08 | 2004-11-08 | |
PCT/US2005/040078 WO2006052775A2 (en) | 2004-11-08 | 2005-11-04 | Peptide anti - tumor agent |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005024161D1 true DE602005024161D1 (de) | 2010-11-25 |
Family
ID=36337037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005024161T Active DE602005024161D1 (de) | 2004-11-08 | 2005-11-04 | Peptid mit antitumoraler wirkung |
Country Status (7)
Country | Link |
---|---|
US (3) | US7173110B2 (de) |
EP (1) | EP1812035B1 (de) |
JP (2) | JP5138378B2 (de) |
AT (1) | ATE484290T1 (de) |
CA (1) | CA2584805C (de) |
DE (1) | DE602005024161D1 (de) |
WO (1) | WO2006052775A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7173110B2 (en) * | 2004-11-08 | 2007-02-06 | New York University | Peptide anti-tumor agent |
KR101351775B1 (ko) * | 2009-04-13 | 2014-01-14 | 이엘씨 매니지먼트 엘엘씨 | 메티오닌 술폭시드 펩티드, 조성물 및 사용 방법 |
JP6007262B2 (ja) * | 2012-01-06 | 2016-10-12 | ノーバス・インターナショナル・インコーポレイテッドNovus International,Inc. | スルホキシドベース界面活性剤 |
RU2620170C1 (ru) * | 2016-08-02 | 2017-05-23 | Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России | Применение катионных пептидов для индукции гибели клеток меланомы кожи человека |
US10584306B2 (en) | 2017-08-11 | 2020-03-10 | Board Of Regents Of The University Of Oklahoma | Surfactant microemulsions |
WO2020150275A1 (en) * | 2019-01-14 | 2020-07-23 | New York University | Cyclic peptide dimers |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4307082A (en) | 1979-07-10 | 1981-12-22 | New York University | Method for the extraction of a factor that mediates contact inhibition of cell growth |
US4530784A (en) | 1983-08-19 | 1985-07-23 | New York University | Large scale extraction process for contact inhibitory factor |
DE3841763A1 (de) * | 1988-12-12 | 1990-06-13 | Basf Ag | Neue tnf-peptide |
US5942492A (en) * | 1996-11-12 | 1999-08-24 | Angstrom Pharmaceuticals, Inc. | Cyclic peptides that bind to urokinase-type plasminogen activator receptor |
US20050124531A1 (en) * | 2002-02-22 | 2005-06-09 | New York University | Biological inhibitions induced by contact inhibitory factor |
JP2004083427A (ja) * | 2002-08-23 | 2004-03-18 | Microbial Chem Res Found | 環状ヘキサペプチド及びプロテアソーム阻害剤 |
US7173110B2 (en) * | 2004-11-08 | 2007-02-06 | New York University | Peptide anti-tumor agent |
-
2005
- 2005-10-31 US US11/264,684 patent/US7173110B2/en active Active
- 2005-11-04 CA CA2584805A patent/CA2584805C/en not_active Expired - Fee Related
- 2005-11-04 JP JP2007540087A patent/JP5138378B2/ja not_active Expired - Fee Related
- 2005-11-04 DE DE602005024161T patent/DE602005024161D1/de active Active
- 2005-11-04 EP EP05823400A patent/EP1812035B1/de not_active Not-in-force
- 2005-11-04 WO PCT/US2005/040078 patent/WO2006052775A2/en active Application Filing
- 2005-11-04 AT AT05823400T patent/ATE484290T1/de not_active IP Right Cessation
-
2006
- 2006-12-22 US US11/615,723 patent/US7691964B2/en active Active
-
2009
- 2009-12-28 US US12/647,899 patent/US8003598B2/en active Active
-
2012
- 2012-08-17 JP JP2012181004A patent/JP2013005804A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1812035B1 (de) | 2010-10-13 |
US7173110B2 (en) | 2007-02-06 |
US7691964B2 (en) | 2010-04-06 |
US20100305044A1 (en) | 2010-12-02 |
JP5138378B2 (ja) | 2013-02-06 |
JP2013005804A (ja) | 2013-01-10 |
US8003598B2 (en) | 2011-08-23 |
US20070123454A1 (en) | 2007-05-31 |
WO2006052775A3 (en) | 2006-07-20 |
US20060258573A1 (en) | 2006-11-16 |
EP1812035A2 (de) | 2007-08-01 |
JP2008518622A (ja) | 2008-06-05 |
WO2006052775A2 (en) | 2006-05-18 |
CA2584805A1 (en) | 2006-05-18 |
CA2584805C (en) | 2014-01-28 |
EP1812035A4 (de) | 2008-04-16 |
ATE484290T1 (de) | 2010-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60332358D1 (de) | Protease-resistente modifizierte interferon alpha polypeptide | |
ES2178000T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
HRP20050585A2 (en) | Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof | |
NZ534919A (en) | Bioactive keratin peptides | |
ATE482972T1 (de) | Tgf-beta1-bindende und geträgerte peptide | |
HK1088840A1 (en) | Stable analogs of glp-1 glp-1 | |
DE602005024161D1 (de) | Peptid mit antitumoraler wirkung | |
HRP20050024A2 (en) | Pegylated t20 polypeptide | |
CY1105616T1 (el) | ΠΕΠΤΙΔΙΑ ΑΝΑΣΤΟΛΕΙΣ ΤΟΥ TGFβ1 | |
ATE342967T1 (de) | Anti-invasive and anti-angiogene urokinase fragmente und deren verwendung | |
NO20062198L (no) | Bradykinin B1 reseptorantagonister | |
CY1116164T1 (el) | Προδρομη 4-σουλφαταση ν-ακετυλογαλακτο σαμινης, μεθοδοι θεραπευτικης αγωγης που χρησιμοποιουν το εν λογω ενζυμο και μεθοδοι για παραγωγη και καθαρισμο του εν λογω ενζυμου | |
CY1118930T1 (el) | Ανασυνδυασμενες πρωτεϊνες ελαστασης και μεθοδοι βιομηχανικης κατασκευης και χρηση αυτων | |
DE60138558D1 (de) | Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung | |
DE602004014145D1 (de) | Von rasgap-abgeleitetes peptid zur gezielten tötung von krebszellen | |
NO20060675L (no) | Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider | |
DE60229867D1 (de) | Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen | |
RS52448B (en) | ANTITUMOR PHARMACEUTICAL COMPOSITION CONTAINING SERALIZIN POLYPEPTIDE FRAGMENTS | |
WO2003093419A3 (en) | Preventing secondary lymphedema with vegf-d dna | |
UA83989C2 (ru) | Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение | |
AU2003260452A8 (en) | Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells | |
IT1294967B1 (it) | Composizione immunogenica da tlp | |
ES2164011B1 (es) | Uso combinado de la quimiocina ip-10 y la interleucina-12 en la preparacion de composiciones para el tratamiento de tumores malignos. | |
WO2007101222A3 (en) | Cancer treatment | |
FR2856598A1 (fr) | Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale |